What is Urofollitropin?

CAS Number: 97048-13-0 | Standard: In-House / IP / EP / BP

Urofollitropin is a highly purified form of follicle-stimulating hormone (FSH) obtained from postmenopausal women. It is processed to ensure high purity, strong biological activity, and consistent therapeutic results. As a key fertility medication, it stimulates ovarian follicle development, improving egg production and enhancing pregnancy success rates in women undergoing ART.

Applications of Urofollitropin

• 1. IVF Ovarian Stimulation: Stimulates ovaries to produce multiple follicles, improve egg quality, and increase the number of retrievable eggs, enhancing IVF success rates.
• 2. Treatment of Female Infertility (PCOS & Unexplained): Supports women with PCOS, anovulation, or unexplained infertility by promoting follicle growth and ovulation.
• 3. Controlled Ovarian Hyperstimulation (COH): Enables predictable, controlled follicle development, optimizing egg quantity and quality for IVF, ICSI, or IUI procedures.
• 4. Intrauterine Insemination (IUI) Support: Stimulates growth of mature follicles and ensures timely ovulation to increase fertilization rates in couples with mild infertility.
• 5. LH Support Therapy (Combined with hCG): Assists women with low LH production to support follicular maturation, trigger ovulation, and create an optimal environment for conception.
• 6. Research & Diagnostic Uses: Utilized in hormonal studies, ovarian reserve testing, and clinical research due to its reliable mechanism and consistent effect on ovarian response.

Significance in Contemporary Fertility Care

• Encourages superior follicle development
• Increases success rates of IUI and IVF
• Provides predictable ovarian response
• Suitable for multiple forms of infertility
• Extensively and safely used in reproductive medicine

Urofollitropin continues to be a key therapeutic agent, offering hope to couples seeking to conceive through assisted reproductive technologies.